Aptargroup (ATR) Cash from Financing Activities (2009 - 2026)
Aptargroup (ATR) posted quarterly Cash from Financing Activities of -$77.9 million for Q2 2026, down 185.89% year-over-year from $90.8 million in Q2 2025, and up 66.16% on a QoQ basis from -$230.3 million in Q1 2026.
Aptargroup (ATR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Aptargroup has reported Cash from Financing Activities for 18 years, with the latest figure at -$77.9 million in Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at -$77.9 million, down 185.89% year-over-year; the trailing twelve-month figure through Jun 2026 was -$223.7 million (up 25.02% YoY), and the FY2025 annual result was -$77.5 million, up 65.62% from the prior year.
- Cash from Financing Activities climbed to -$77.9 million in Q2 2026, from -$230.3 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $211.9 million in Q1 2022 and troughed at -$230.3 million in Q1 2026.
- A 5-year average of -$52.5 million and a median of -$55.7 million in 2023 frame the typical range for Cash from Financing Activities.
- The largest YoY upside for Cash from Financing Activities was 570.77% in 2022 against a maximum downside of 32697.49% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at -$82.0 million in 2022, then advanced by 5.42% to -$77.5 million in 2023, then retreated by 13.09% to -$87.7 million in 2024, then soared by 187.53% to $76.8 million in 2025, then plunged by 201.55% to -$77.9 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$77.9 million in Q2 2026, -$230.3 million in Q1 2026, and $76.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Aptargroup | 8.58 Bn | 8.38 Bn | 365.52 Mn | -77.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77.95 Mn |
| Jun 30, 2026 | -77.95 Mn |
| Mar 31, 2026 | -230.34 Mn |
| Mar 31, 2026 | -230.34 Mn |
| Dec 31, 2025 | 76.76 Mn |
| Dec 31, 2025 | 76.76 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | -27.27 Mn |
| Jun 30, 2025 | -27.27 Mn |
| Mar 31, 2025 | -134.78 Mn |
| Mar 31, 2025 | -134.78 Mn |
| Dec 31, 2024 | -87.69 Mn |
| Dec 31, 2024 | -87.69 Mn |
| Sep 30, 2024 | -48.64 Mn |
| Sep 30, 2024 | -48.64 Mn |
| Jun 30, 2024 | -53.26 Mn |
| Jun 30, 2024 | -53.26 Mn |
| Mar 31, 2024 | -35.75 Mn |
| Mar 31, 2024 | -35.75 Mn |